Article
High versus standard doses interferon-alpha in the treatment of naïve chronic hepatitis C patients in Taiwan: a 10-year cohort study.
BMC infectious diseases - 12 Apr 2005
Yu Ming-Lung, Dai Chia-Yen, Chen Shinn-Cherng, Lee Li-Po, Hsieh Ming-Yen, Lin Zu-Yau, Hsieh Ming-Yuh, Wang Liang-Yen, Tsai Jung-Fa, Chang Wen-Yu, Chuang Wan-Long
Abstract excerpt
BACKGROUND: Interferon-alpha monotherapy is effective in less than one-third patients with chronic hepatitis C. The dose-effect, tolerability and durability of interferon-alpha treatment and its long-term effect on the prevention of cirrhosis and hepatocellular carcinoma in naive Taiwanese patients with chronic hepatitis C have not been well investigated. We conducted the present cohort study treated with high...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
